Urinary angiotensinogen and urinary sodium are associated with blood pressure in normoalbuminuric children with diabetes

Pediatric Nephrology

Volumn 29, Issue 12, 2014, Pages 2373-2378

  Soltysiak, Jolanta ^a   Skowronska, Bogda ^a   Fichna, Piotr ^a   Ostalska Nowicka, Danuta ^a   Stankiewicz, Witold ^a   Lewandowska Stachowiak, Maria ^a   Lipkowska, Katarzyna ^a   Zachwieja, Jacek ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Ambulatory blood pressure monitoring; Diabetic kidney disease; Hypertension

Indexed keywords

EID: 84939891120     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-014-2861-0     Document Type: Article

References (40)

1. Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, Saran R, Wang AY, Yang CW (2013) Chronic kidney disease: global dimension and perspectives. Lancet 382:260–272
2. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977–986
3. Donaghue KC, Chiarelli F, Trotta D, Allgrove J, Dahl-Jorgensen K (2009) Microvascular and macrovascular complications associated with diabetes in children and adolescents. Pediatr Diabetes 10(Suppl 12):195–203
4. Perkins BA, Krolewski AS (2005) Early nephropathy in type 1 diabetes: a new perspective on who will and who will not progress. Curr Diab Rep 5:455–463
5. Eknoyan G, Hostetter T, Bakris GL, Hebert L, Levey AS, Parving HH, Steffes MW, Toto R (2003) Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK). Am J Kidney Dis 42:617–622
6. Dalla Vestra M, Saller A, Bortoloso E, Mauer M, Fioretto P (2000) Structural involvement in type 1 and type 2 diabetic nephropathy. Diabetes Metab 26(Suppl 4):8–14
7. Perkins BA, Ficociello LH, Silva KH, Finkelstein DM, Warram JH, Krolewski AS (2003) Regression of microalbuminuria in type 1 diabetes. N Engl J Med 348:2285–2293
8. Taguma Y, Kitamoto Y, Futaki G, Ueda H, Monma H, Ishizaki M, Takahashi H, Sekino H, Sasaki Y (1985) Effect of captopril on heavy proteinuria in azotemic diabetics. N Engl J Med 313:1617–1620
9. Nagai Y, Yao L, Kobori H, Miyata K, Ozawa Y, Miyatake A, Yukimura T, Shokoji T, Kimura S, Kiyomoto H, Kohno M, Abe Y, Nishiyama A (2005) Temporary angiotensin II blockade at the prediabetic stage attenuates the development of renal injury in type 2 diabetic rats. J Am Soc Nephrol 16:703–711
10. Yoo TH, Li JJ, Kim JJ, Jung DS, Kwak SJ, Ryu DR, Choi HY, Kim JS, Kim HJ, Han SH, Lee JE, Han DS, Kang SW (2007) Activation of the renin-angiotensin system within podocytes in diabetes. Kidney Int 71:1019–1027
11. Kamiyama M, Zsombok A, Kobori H (2012) Urinary angiotensinogen as a novel early biomarker of intrarenal renin-angiotensin system activation in experimental type 1 diabetes. J Pharmacol Sci 119:314–323
12. Saito T, Urushihara M, Kotani Y, Kagami S, Kobori H (2009) Increased urinary angiotensinogen is precedent to increased urinary albumin in patients with type 1 diabetes. Am J Med Sci 338:478–480
13. Ogawa S, Kobori H, Ohashi N, Urushihara M, Nishiyama A, Mori T, Ishizuka T, Nako K, Ito S (2009) Angiotensin II Type 1 receptor blockers reduce urinary angiotensinogen excretion and the levels of urinary markers of oxidative stress and inflammation in patients with type 2 diabetic nephropathy. Biomark Insights 4:97–102
14. Castrop H, Höcherl K, Kurtz A, Schweda F, Todorov V, Wagner C (2010) Physiology of kidney renin. Physiol Rev 90:607–673
15. Kobori H, Nishiyama A, Harrison-Bernard LM, Navar LG (2003) Urinary angiotensinogen as an indicator of intrarenal Angiotensin status in hypertension. Hypertension 41:42–49
16. Ying J, Stuart D, Hillas E, Gociman BR, Ramkumar N, Lalouel JM, Kohan DE (2012) Overexpression of mouse angiotensinogen in renal proximal tubule causes salt-sensitive hypertension in mice. Am J Hypertens 25:684–689
17. Ramkumar N, Stuart D, Ying J, Kohan DE (2013) A possible interaction between systemic and renal angiotensinogen in the control of blood pressure. Am J Hypertens 26:473–480
18. Matsusaka T, Niimura F, Shimizu A, Pastan I, Saito A, Kobori H, Nishiyama A, Ichikawa I (2012) Liver angiotensinogen is the primary source of renal angiotensin II. J Am Soc Nephrol 23:1181–1189
19. Vidotti DB, Casarini DE, Cristovam PC, Leite CA, Schor N, Boim MA (2004) High glucose concentration stimulates intracellular renin activity and angiotensin II generation in rat mesangial cells. Am J Physiol Renal Physiol 286:F1039–F1045
20. Ramkumar N, Kohan DE (2013) Proximal tubule angiotensinogen modulation of arterial pressure. Curr Opin Nephrol Hypertens 22:32–36
21. Raile K, Galler A, Hofer S, Herbst A, Dunstheimer D, Busch P, Holl RW (2007) Diabetic nephropathy in 27,805 children, adolescents, and adults with type 1 diabetes: effect of diabetes duration, A1C, hypertension, dyslipidemia, diabetes onset, and sex. Diabetes Care 30:2523–2528
22. Fukuda M, Urushihara M, Wakamatsu T, Oikawa T, Kobori H (2012) Proximal tubular angiotensinogen in renal biopsy suggests nondipper BP rhythm accompanied by enhanced tubular sodium reabsorption. J Hypertens 30:1453–1459
23. Kobori H, Urushihara M, Xu JH, Berenson GS, Navar LG (2010) Urinary angiotensinogen is correlated with blood pressure in men (Bogalusa Heart Study). J Hypertens 28:1422–1428
24. Chiarelli F, Trotta D, Verrotti A, Mohn A (2002) Treatment of hypertension and microalbuminuria in children and adolescents with type 1 diabetes mellitus. Pediatr Diabetes 3:113–124
25. Nishizaki N, Hirano D, Nishizaki Y, Fujinaga S, Nagata S, Ohtomo Y, Kaneko K, Shimizu T (2013) Increased urinary angiotensinogen is an effective marker of chronic renal impairment in very low birth weight children. Clin Exp Nephrol. doi:10.1007/s10157-013-0896-3t
26. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114(2 Suppl 4th Report):555–576
27. Marre M, Hallab M, Roy J, Lejeune JJ, Jallet P, Fressinaud P (1992) Glomerular hyperfiltration in type 1, type 2, and secondary diabetes. J Diabet Complicat 6:19–24
28. Rewers M, Pihoker C, Donaghue K, Hanas R, Swift P, Klingensmith GJ (2009) Assessment and monitoring of glycemic control in children and adolescents with diabetes. Pediatr Diabetes 10(Suppl 12):71–81
29. Amoore JN, Dewar D, Gough K, Padfield PL (2005) Do SpaceLabs ambulatory non-invasive blood pressure recorders measure blood pressure consistently over several years use? Blood Press Monit 10:51–56
30. Soergel M, Kirschstein M, Busch C, Danne T, Gellermann J, Holl R, Krull F, Reichert H, Reusz GS, Rascher W (1997) Oscillometric twenty-four-hour ambulatory blood pressure values in healthy children and adolescents: a multicenter trial including 1141 subjects. J Pediatr 130:178–184
31. Wühl E, Witte K, Soergel M, Mehls O, Schaefer F, German Working Group on Pediatric Hypertension (2002) Distribution of 24-h ambulatory blood pressure in children: normalized reference values and role of body dimensions. J Hypertens 20:1995–2007
32. Zou J, Li Y, Li FH, Wei FF, Wang JG (2012) Urinary angiotensinogen excretion and ambulatory blood pressure. J Hypertens 30:2000–2006
33. Kuroczycka-Saniutycz E, Wasilewska A, Sulik A, Milewski R (2013) Urinary angiotensinogen as a marker of intrarenal angiotensin II activity in adolescents with primary hypertension. Pediatr Nephrol 28:1113–1119
34. Franco M, Tapia E, Santamaría J, Zafra I, García-Torres R, Gordon KL, Pons H, Rodríguez-Iturbe B, Johnson RJ, Herrera-Acosta J (2001) Renal cortical vasoconstriction contributes to development of salt-sensitive hypertension after angiotensin II exposure. J Am Soc Nephrol 12:2263–2271
35. Kobori H, Harrisom-Bernard LM, Navar LG (2002) Urinary excretion of angiotensinogen reflects intrarenal angiotensinogen production. Kidney Int 61:579–585
36. Lantelme P, Rohrwasser A, Gociman B, Hillas E, Cheng T, Petty G, Thomas J, Xiao S, Ishigami T, Herrmann T, Terreros DA, Ward K, Lalouel JM (2002) Effects of dietary sodium and genetic background on angiotensinogen and Renin in mouse. Hypertension 39:1007–1014
37. Vallon V, Blantz R, Thomson S (2005) The salt paradox and its possible implications in managing hypertensive diabetic patients. Curr Hypertens Rep 7:141–147
38. Vallon V, Blantz RC, Thomson S (2003) Glomerular hyperfiltration and the salt paradox in early [corrected] type 1 diabetes mellitus: a tubulo-centric view. J Am Soc Nephrol 14:530–537
39. Wühl E, Schaefer F (2011) Managing kidney disease with blood-pressure control. Nat Rev Nephrol 7:434–444
40. Feldt-Rasmussen B, Mathiesen ER, Deckert T, Giese J, Christensen NJ, Bent-Hansen L, Nielsen MD (1987) Central role for sodium in the pathogenesis of blood pressure changes independent of angiotensin, aldosterone and catecholamines in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 30:610–617